Novartis Ag NVS
NYSE NVS
$150.59 +0.21 (+0.14%)
As of: Oct 16, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Gains from Investment Securities (2009 - 2012)

Updated

Analysis

Novartis Ag (NVS) Gains from Investment Securities (2009 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -1.24 Bn
Sep 30, 2012 107.00 Mn
Mar 31, 2012 15.00 Mn
Dec 31, 2011 -11.00 Mn
Sep 30, 2011 -10.00 Mn
Jun 30, 2011 239.00 Mn
Mar 31, 2011 1.37 Bn
Dec 31, 2010 -190.00 Mn
Sep 30, 2010 15.84 Bn
Jun 30, 2010 -2.70 Bn
Mar 31, 2010 -319.00 Mn
Dec 31, 2009 -3.04 Bn
Sep 30, 2009 -3.11 Bn
API Access

Novartis Ag Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=NVS&period=max&api_key=YOUR_API_KEY